最新更新 :
27/11/2024
降圧薬   Clonidine hydrochloride  
注射薬
カプセル 紙袋 経口液
溶媒内の安定性 混合時の安定性 安定性に影響する因子 互換性 投与経路 引用文献 PDF
   化学構造  

商品名   商品名     

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Catapres アイルランド, アーストラリア, イギリス, ニュージーランド
Catapresan イタリア, オランダ, オーストリア, ギリシア, スイス, スウェーデン, スペイン, ドイツ, フィンランド, ベネズエラ
Catapressan チュニジア, フランス, ベルギー, モロッコ, ルクセンブルグ
Clonidin ドイツ, ブラジル
Clonidina アルゼンチン, スペイン, チリ, ベネズエラ
Clonipres ベネズエラ
Haemiton ドイツ
Lowpres ベネズエラ
Paracefan ドイツ
引用文献   注射薬   引用文献 : Clonidine hydrochloride  
形式 出版物
186 雑誌 Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
346 雑誌 Wulf H, Gleim M, Mignat C.
The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes.
J Pain Symptom Manage 1994 ; 9: 308-311.
650 雑誌 Trissel LA, Hassenbusch SJ.
Development of clonidine hydrochloride injections for epidural and intrathecal administration.
Int J Pharm Compound 1997 ; 1: 274-277.
1506 雑誌 Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
EJHP 2015 ;22:107-112.
1508 雑誌 Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
1516 実験 Ropivacaine (Naropeine®) - Summary of Product Characteristics
Mercury Pharmaceuticals Limited 2012
1601 雑誌 Godwin DA, Kim NH, Zuniga R.
Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration.
Hosp Pharm 2001 ; 36: 950-954.
1665 雑誌 Öster Svedberg K, McKenzie J, Larrivee-Elkins C.
Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.
J Clin Pharm Ther 2002 ; 21: 39-45.
1708 雑誌 Xu QA, Trissel LA, Pham L.
Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.
Int J Pharm Compound 2002 ; 6: 66-69.
1869 雑誌 Hildebrand KR, Elsberry DD, Hassenbusch SJ.
Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
J Pain Symptom Manage 2003 ; 25, 5: 464-471.
1928 雑誌 Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P.
Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
J Pain Symptom Manage 2004 ; 28, 3: 268-272.
1948 雑誌 Classen AM, Wimbish GH, Kupiec TC.
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
J Pain Symptom Manage 2004 ; 28, 6: 603-611.
2018 雑誌 Veggeland T.
Visual compatibility of clonidine with selected drugs.
Am J Health-Syst Pharm 2005 ; 62: 1968-1969.
2184 雑誌 Vranken JH, van Kan HJM, ven der Vegt MH.
Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes.
J Pain Symptom Manage 2006 ; 32, 4: 297-299.
2248 雑誌 Shields D, Montenegro R.
Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Neuromodulation 2007 ; 10, 1: 6-11.
2305 雑誌 Bianchi F, Ginggen A, Tardy Y.
Stability and compatibility of drug mixtures in an implantable infusion system.
Anaesthesia 2008 63, 9: 972-978.
2317 雑誌 Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G.
Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia.
EJHP Science 2009 ; 15, 1: 3-5.
3507 実験 Chirocaine - Summary of Product Characteristics
AbbVie 2013
3705 雑誌 Knudsen L, Eisend S, Haake N, Kunze T.
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
EJHP 2014 ;21:161-166
3728 雑誌 Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3823 雑誌 Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
4011 雑誌 Gersonde F, Eisend S, Haake N, Kunze T.
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
EJHP 2016 2016;0:1-11
4130 雑誌 Koller AK, Krebs S, Dörje F.
Untersuchungen zur Kompatibilität von Clonidin mit häufig eingesetzen Arzneimittel auf Intensivstationen.
Pharmaceutics 2021 , 13, 21.
4538 雑誌 Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K.
Compatibility of pentoxifylline and parenteral medications.
Archives of Disease in Childhood 2020 ; 105: 395-397.
4643 雑誌 Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L.
Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes.
EJHP 2021
4698 雑誌 Ayari G, D'Huart E, Vigneron J, Demoré B.
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Pharmaceutical Technology in Hospital Pharmacy 2022
4730 雑誌 Sorrieul J, Robert J, Vincent L, Andre M, Bourcier B, Bienfait F, Jubier Hamon S, Dupoiron D, Devys C.
Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures.
Neuromodulation 2022
4837 雑誌 De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.
4842 雑誌 Souha H Y, Alka G, Yunmei S, Nicole E W, Sanjay G.
Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors
Drug Design Dev Ther 2024 Drug Design, Development

  Mentions Légales